Nipro Corp – Strategy, SWOT and Corporate Finance Report

Nipro Corp – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company

Key Highlights

Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary products, double bags, pre-filled syringes, half-type kits among others. It offers contract manufacturing services of injection, oral and external use drug formulations. Nipro also provides glass molding vials, ampoules, syringes, and cartridges; glass tubes for pharmaceuticals; glass forming machinery; other parts of pharmaceutical packaging including rubber plugs; and glass bulbs for vacuum flasks. The company has sales offices in North America, South America, Europe, Asia and Africa. Nipro is headquartered in Osaka, Japan.

Scope

Detailed information on Nipro Corp required for business and competitor intelligence needs

A study of the major internal and external factors affecting Nipro Corp in the form of a SWOT analysis

An in-depth view of the business model of Nipro Corp including a breakdown and examination of key business segments

News about Nipro Corp, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Nipro Corp and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Nipro Corp as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Nipro Corps business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Terumo Corp

Taiho Pharmaceutical Co Ltd

Mitsubishi Tanabe Pharma Corp

Maquet Holding BV & Co KG

Kyowa Kirin Co Ltd

Fresenius SE & Co KGaA

Chugai Pharmaceutical Co Ltd

B. Braun Melsungen AG

Asahi Kasei Medical Co Ltd

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Nipro Corp - Key Facts

Nipro Corp - Key Employees

Nipro Corp - Major Products and Services

Nipro Corp - History

Nipro Corp - Company Statement

Nipro Corp - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 Company Analysis

Company Overview

Nipro Corp - Business Description

Business Segment: Medical Related

Overview

Performance

Business Segment: Other

Overview

Performance

Business Segment: Pharma Packaging

Overview

Performance

Business Segment: Pharmaceutical Related

Overview

Performance

Geographical Segment: America

Performance

Geographical Segment: Asia

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Japan

Performance

R&D Overview

Nipro Corp - Corporate Strategy

Nipro Corp - SWOT Analysis

SWOT Analysis - Overview

Nipro Corp - Strengths

Nipro Corp - Weaknesses

Nipro Corp - Opportunities

Nipro Corp - Threats

Nipro Corp - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Nipro Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Nipro Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Nipro Corp, Recent Deals Summary

Section 5 Company’s Recent Developments

Jan 15, 2019: Summary of Management Policy announced by President Yoshihiko Sano of Nipro, delivered at the New Year’s Management Meeting on January 12, 2019

Jan 13, 2018: Summary of management policy announced by president Yoshihiko Sano of Nipro, delivered at the New Year’s Management Meeting on January 13, 2018

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Nipro Corp, Key Facts

Nipro Corp, Key Employees

Nipro Corp, Major Products and Services

Nipro Corp, History

Nipro Corp, Other Locations

Nipro Corp, Subsidiaries

Nipro Corp, Joint Venture

Nipro Corp, Key Competitors

Nipro Corp, Ratios based on current share price

Nipro Corp, Annual Ratios

Nipro Corp, Annual Ratios (Cont…1)

Nipro Corp, Annual Ratios (Cont…2)

Nipro Corp, Interim Ratios

Nipro Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Nipro Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Nipro Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Nipro Corp, Performance Chart (2015 – 2019)

Nipro Corp, Ratio Charts

Nipro Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Nipro Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports